Segmental Ipsilateral Odontognathic Dysplasia (Mandibular Involvement in Segmental Odontomaxillary Dysplasia?) and Identification of PIK3CA Somatic Variant in Lesional Mandibular Gingival Tissue.


Journal

Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 24 11 2019
accepted: 29 05 2020
pubmed: 6 6 2020
medline: 11 11 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Segmental odontomaxillary dysplasia (SOD) is a developmental condition of the middle and posterior maxilla featuring dysplastic bone overgrowth, dental abnormalities and, occasionally, various homolateral cutaneous manifestations. Herein, we describe an individual with maxillary abnormality akin to SOD and associated ipsilateral segmental odontomandibular dysplasia. Also, the result of the evaluation of lesional mandibular gingival tissue for overgrowth-related gene variants is reported. An 8-year-old girl presented clinically with congenital maxillary and mandibular alveolar soft tissue enlargement in the area of the premolars. A panoramic radiograph revealed abnormal trabeculation essentially similar to SOD in the maxilla and mandible with congenitally missing maxillary and mandibular first and second premolars and mandibular canines. Diagnostic mandibular bone biopsy was performed and lesional mandibular gingival hyperplastic tissue was obtained for variant analysis of somatic overgrowth genes PIK3CA, AKT1, AKT3, GNAQ, GNA11, MTOR, PIK3R2. Cone beam computerized tomography (CBCT) disclosed osseous abnormalities on the left side of the maxilla and mandible and very mild osseous expansion in the mandible. Histologically, abnormal bone exhibiting prominent reversal lines was present and associated with fibrocollagenous tissue. Genomic DNA analysis disclosed PIK3CAc.1571G>A; pArg524Lys which was seen at a low mosaic level in the blood, indicating a post-zygotic change. Although this case may be a unique disorder, by sharing features with SOD, one can suggest the possibility of mandibular involvement in SOD. The presence of a PIK3CA variant may support the hypothesis that these segmental disorders could be part of the PIK3CA-related overgrowth spectrum.

Identifiants

pubmed: 32500425
doi: 10.1007/s12105-020-01185-5
pii: 10.1007/s12105-020-01185-5
pmc: PMC8010023
doi:

Substances chimiques

Class I Phosphatidylinositol 3-Kinases EC 2.7.1.137
PIK3CA protein, human EC 2.7.1.137

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

368-373

Références

BMC Cancer. 2013 Dec 17;13:602
pubmed: 24341335
Cutis. 2014 Oct;94(4):E18-21
pubmed: 25372264
Am J Med Genet C Semin Med Genet. 2016 Dec;172(4):402-421
pubmed: 27860216
J Am Acad Dermatol. 1987 Apr;16(4):899-906
pubmed: 3033033
Am J Med Genet. 1997 Jan 31;68(3):357-61
pubmed: 9024572
Int J Dermatol. 2002 Jul;41(7):384-6
pubmed: 12121546
J Am Dent Assoc. 2018 Feb;149(2):153-162
pubmed: 29389339
Dev Biol. 2015 Aug 1;404(1):14-26
pubmed: 25958091
Oral Surg Oral Med Oral Pathol. 1990 Jul;70(1):81-5
pubmed: 2371053
Trends Mol Med. 2018 Oct;24(10):856-870
pubmed: 30197175
Oral Surg Oral Med Oral Pathol. 1987 Oct;64(4):445-8
pubmed: 3477765
J Am Acad Dermatol. 2004 Dec;51(6):965-9
pubmed: 15583590
Pediatr Res. 2017 Nov;82(5):850-854
pubmed: 28665924
JCI Insight. 2016 Jun 16;1(9):
pubmed: 27631024
Asian Pac J Cancer Prev. ;18(1):57-64
pubmed: 28240010
Ann Dermatol Venereol. 1981;108(1):41-6
pubmed: 7235503
Oncol Lett. 2016 Nov;12(5):3264-3272
pubmed: 27899992
Am J Med Genet A. 2014 Jul;164A(7):1713-33
pubmed: 24782230
Clin Dysmorphol. 2016 Jan;25(1):16-8
pubmed: 26351730
Genome Res. 1998 Mar;8(3):186-94
pubmed: 9521922
Genet Med. 2017 Sep;19(9):989-997
pubmed: 28151489
J Invest Dermatol. 2017 Aug;137(8):1795-1798
pubmed: 28347698
Pediatr Dermatol. 2004 Jul-Aug;21(4):448-51
pubmed: 15283787
Genome Res. 1998 Mar;8(3):175-85
pubmed: 9521921
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Oct;90(4):483-8
pubmed: 11027387
Nat Rev Genet. 2006 Aug;7(8):606-19
pubmed: 16847462
Infect Agent Cancer. 2018 Dec 29;13:43
pubmed: 30619505

Auteurs

Tanya M Gibson (TM)

Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Missouri-Kansas City, Kansas City, USA.

Keith Rafferty (K)

Genetic Diagnostic Laboratory, University of Pennsylvania, Philadelphia, PA, USA.

Elyse Ryan (E)

Genetic Diagnostic Laboratory, University of Pennsylvania, Philadelphia, PA, USA.

Arupa Ganguly (A)

Genetic Diagnostic Laboratory, University of Pennsylvania, Philadelphia, PA, USA.

Ioannis G Koutlas (IG)

Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, 515 Delaware Street SE #16-116B, Minneapolis, MN, 55455, USA. koutl001@umn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH